This article provides a comprehensive overview of the principles and practices of analytical validation for molecular diagnostics in oncology.
This article provides a comprehensive comparison of Next-Generation Sequencing (NGS) and Sanger sequencing for cancer mutation detection, tailored for researchers and drug development professionals.
This article provides a comprehensive framework for implementing robust quality control (QC) metrics in cancer genomic profiling using targeted gene panels.
This article provides a comprehensive analysis of the challenges and innovative solutions surrounding false positives in circulating tumor DNA (ctDNA) detection, a critical barrier in liquid biopsy applications.
Obtaining high-quality, high-yield DNA from tumor samples is a critical yet challenging step in modern oncology research and drug development.
This article provides a comprehensive framework for understanding, correcting, and validating batch effects in cancer genomic studies.
Tumor heterogeneity presents a fundamental challenge to accurate molecular diagnosis and effective targeted therapy in oncology.
This comprehensive review addresses the critical role of sample quality in cancer molecular testing, a fundamental determinant of diagnostic accuracy and research validity.
This article provides a comprehensive analysis of Variants of Uncertain Significance (VUS) management in cancer genetics for researchers and drug development professionals.
Single-cell RNA sequencing (scRNA-seq) has revolutionized our understanding of tumor heterogeneity by characterizing the complex cellular ecosystems of cancers at unprecedented resolution.